Search research articles
Contact Us
Filters
Showing results (21-30 of 25) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 25 results.
Asian Pacific Journal of Cancer Prevention : APJCP
|
May 29, 2024
Nationwide Study of Factors Impacting Survival Outcome and Consequences in Children with Reactivation/Refractory Langerhans Cell Histiocytosis
Chalinee Monsereenusorn, Kunanya Suwannaying, Jassada Buaboonnam, et al.
BMC Cancer
|
October 18, 2019
Clinical outcomes and prognostic factors to predict treatment response in high risk neuroblastoma patients receiving topotecan and cyclophosphamide containing induction regimen: a prospective multicenter study
Piya Rujkijyanont, Apichat Photia, Chanchai Traivaree, et al.
Pediatric Blood & Cancer
|
May 13, 2022
Treatment outcomes among high-risk neuroblastoma patients receiving non-immunotherapy regimen: Multicenter study on behalf of the Thai Pediatric Oncology Group
Kunanya Suwannaying, Chalinee Monsereenusorn, Piya Rujkijyanont, et al.
JCO Global Oncology
|
September 1, 2023
Current Challenges of Asian National Children's Cancer Study Groups on Behalf of Asian Pediatric Hematology and Oncology Group
Chi-Kong Li, Purna Kurkure, Ramandeep Singh Arora, et al.
Eclinicalmedicine
|
December 8, 2025
Landscape of paediatric oncology clinical trials in Asia
Muhammad Saghir Khan, Daisuke Tomizawa, Huyung Zheng, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 25) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 25 results.
Asian Pacific Journal of Cancer Prevention : APJCP
|
May 29, 2024
Nationwide Study of Factors Impacting Survival Outcome and Consequences in Children with Reactivation/Refractory Langerhans Cell Histiocytosis
Chalinee Monsereenusorn, Kunanya Suwannaying, Jassada Buaboonnam, et al.
BMC Cancer
|
October 18, 2019
Clinical outcomes and prognostic factors to predict treatment response in high risk neuroblastoma patients receiving topotecan and cyclophosphamide containing induction regimen: a prospective multicenter study
Piya Rujkijyanont, Apichat Photia, Chanchai Traivaree, et al.
Pediatric Blood & Cancer
|
May 13, 2022
Treatment outcomes among high-risk neuroblastoma patients receiving non-immunotherapy regimen: Multicenter study on behalf of the Thai Pediatric Oncology Group
Kunanya Suwannaying, Chalinee Monsereenusorn, Piya Rujkijyanont, et al.
JCO Global Oncology
|
September 1, 2023
Current Challenges of Asian National Children's Cancer Study Groups on Behalf of Asian Pediatric Hematology and Oncology Group
Chi-Kong Li, Purna Kurkure, Ramandeep Singh Arora, et al.
Eclinicalmedicine
|
December 8, 2025
Landscape of paediatric oncology clinical trials in Asia
Muhammad Saghir Khan, Daisuke Tomizawa, Huyung Zheng, et al.
Page
of 3